|
|
| (13 intermediate revisions by 3 users not shown) |
| Line 21: |
Line 21: |
| | height: 100%; | | height: 100%; |
| | z-index: 9999; | | z-index: 9999; |
| − | background: #2B2B35; | + | background: #292935; |
| | } | | } |
| | | | |
| Line 59: |
Line 59: |
| | <body> | | <body> |
| | <div class="se-pre-con"> | | <div class="se-pre-con"> |
| − | <img src="https://2019.igem.org/wiki/images/8/83/T--Tuebingen--preloader.gif"> | + | <img src="https://2019.igem.org/wiki/images/4/49/T--Tuebingen--DNA_gif.gif"> |
| | </div> | | </div> |
| | <script src="https://2019.igem.org/Team:Tuebingen/jqueryLoadJS?action=raw&ctype=text/javascript"></script> | | <script src="https://2019.igem.org/Team:Tuebingen/jqueryLoadJS?action=raw&ctype=text/javascript"></script> |
| Line 6,068: |
Line 6,068: |
| | | | |
| | .bg-dark { | | .bg-dark { |
| − | background-color: #343a40 !important | + | background-color: #232323 !important |
| | } | | } |
| | | | |
| Line 9,158: |
Line 9,158: |
| | } | | } |
| | | | |
| − | .judges-will-not-evaluate {
| + | |
| − | border: 4px solid #e4dede;
| + | |
| − | padding: 2% !important;
| + | |
| − | width: 92% !important;
| + | |
| − | }
| + | |
| | | | |
| | /* OWN Global Settings */ | | /* OWN Global Settings */ |
| Line 9,317: |
Line 9,313: |
| | | | |
| | .dropdown-menu { | | .dropdown-menu { |
| − | background-color: rgba(100, 100, 100, 1); | + | background-color: #232323; |
| | } | | } |
| | | | |
| Line 9,766: |
Line 9,762: |
| | </style> | | </style> |
| | <head> | | <head> |
| − | <title>GLP.exe</title> | + | <title>GLP.exe - Nissle</title> |
| | <meta charset="utf-8"> | | <meta charset="utf-8"> |
| | <meta name="viewport" content="width=device-width, initial-scale=1"> | | <meta name="viewport" content="width=device-width, initial-scale=1"> |
| Line 10,260: |
Line 10,256: |
| | <body style=""> | | <body style=""> |
| | <section id="nav-placeholder"> | | <section id="nav-placeholder"> |
| − | <nav class="shadow navbar navbar-expand-md navbar-dark fixed-top"
| + | <nav class="shadow navbar navbar-expand-md navbar-dark fixed-top" |
| | style="background-color: rgba(30, 30, 30, 0.3); z-index: 100;"> | | style="background-color: rgba(30, 30, 30, 0.3); z-index: 100;"> |
| | <a class="navbar-brand" href="https://2019.igem.org/Team:Tuebingen"> | | <a class="navbar-brand" href="https://2019.igem.org/Team:Tuebingen"> |
| Line 10,274: |
Line 10,270: |
| | <li id="ourStoryButton" class="nav-item mx-3"> | | <li id="ourStoryButton" class="nav-item mx-3"> |
| | <a class="nav-link" href="/Team:Tuebingen/Story" | | <a class="nav-link" href="/Team:Tuebingen/Story" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">OUR STORY</a> | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">OUR |
| | + | STORY</a> |
| | </li> | | </li> |
| | | | |
| Line 10,291: |
Line 10,288: |
| | <a class="dropdown-item" href="/Team:Tuebingen/Incretin" | | <a class="dropdown-item" href="/Team:Tuebingen/Incretin" |
| | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Incretin</a> | | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Incretin</a> |
| − | <a class="dropdown-item" href="/Team:Tuebingen/CPP" | + | <a class="dropdown-item" href="/Team:Tuebingen/Model" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Cell Penetrating Peptides</a> | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a> |
| | + | <a class="dropdown-item" href="/Team:Tuebingen/Software" |
| | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Software</a> |
| | <a class="dropdown-item" href="/Team:Tuebingen/Results" | | <a class="dropdown-item" href="/Team:Tuebingen/Results" |
| | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Results</a> | | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Results</a> |
| Line 10,299: |
Line 10,298: |
| | <a class="dropdown-item" href="/Team:Tuebingen/Notebook" | | <a class="dropdown-item" href="/Team:Tuebingen/Notebook" |
| | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Notebook</a> | | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Notebook</a> |
| − | <a class="dropdown-item" href="/Team:Tuebingen/Model"
| |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a>
| |
| − | <a class="dropdown-item" href="/Team:Tuebingen/Software"
| |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Software</a>
| |
| | <a class="dropdown-item" href="/Team:Tuebingen/Outlook" | | <a class="dropdown-item" href="/Team:Tuebingen/Outlook" |
| | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Outlook</a> | | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Outlook</a> |
| | + | <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship" |
| | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Entrepreneurship</a> |
| | </div> | | </div> |
| | </li> | | </li> |
| Line 10,314: |
Line 10,311: |
| | <div class="dropdown-menu"> | | <div class="dropdown-menu"> |
| | <a class="dropdown-item" href="/Team:Tuebingen/Parts" | | <a class="dropdown-item" href="/Team:Tuebingen/Parts" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Parts Overview</a> | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Parts |
| | + | Overview</a> |
| | <a class="dropdown-item" href="/Team:Tuebingen/Basic_Part" | | <a class="dropdown-item" href="/Team:Tuebingen/Basic_Part" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Basic Parts</a> | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Basic |
| | + | Parts</a> |
| | <a class="dropdown-item" href="/Team:Tuebingen/Improved_Part" | | <a class="dropdown-item" href="/Team:Tuebingen/Improved_Part" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Improved Parts</a> | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Improved |
| | + | Parts</a> |
| | + | <a class="dropdown-item" href="/Team:Tuebingen/Characterized_Part" |
| | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Characterized |
| | + | Parts</a> |
| | <a class="dropdown-item" href="/Team:Tuebingen/Composite_Part" | | <a class="dropdown-item" href="/Team:Tuebingen/Composite_Part" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Composite Parts</a> | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Composite |
| | + | Parts</a> |
| | <a class="dropdown-item" href="/Team:Tuebingen/Part_Collection" | | <a class="dropdown-item" href="/Team:Tuebingen/Part_Collection" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Part Collection</a> | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Part |
| | + | Collection</a> |
| | + | <a class="dropdown-item" href="/Team:Tuebingen/Downloads" |
| | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Downloads</a> |
| | </div> | | </div> |
| | </li> | | </li> |
| Line 10,336: |
Line 10,343: |
| | <a class="dropdown-item" href="/Team:Tuebingen/Collaborations" | | <a class="dropdown-item" href="/Team:Tuebingen/Collaborations" |
| | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Collaborations</a> | | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Collaborations</a> |
| − | <a class="dropdown-item" href="/Team:Tuebingen/Attributions"
| |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Attributions</a>
| |
| | <a class="dropdown-item" href="/Team:Tuebingen/Sponsors" | | <a class="dropdown-item" href="/Team:Tuebingen/Sponsors" |
| | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sponsors</a> | | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sponsors</a> |
| | + | <a class="dropdown-item" href="/Team:Tuebingen/Attributions" |
| | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Attributions</a> |
| | <a class="dropdown-item" href="/Team:Tuebingen/Gallery" | | <a class="dropdown-item" href="/Team:Tuebingen/Gallery" |
| | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Gallery</a> | | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Gallery</a> |
| Line 10,354: |
Line 10,361: |
| | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Overview</a> | | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Overview</a> |
| | <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement" | | <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public Engagement</a> |
| − | Engagement</a>
| + | |
| | <a class="dropdown-item" href="/Team:Tuebingen/Experts" | | <a class="dropdown-item" href="/Team:Tuebingen/Experts" |
| | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experts</a> | | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experts</a> |
| − | <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship"
| |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Entrepreneurship</a>
| |
| | <a class="dropdown-item" href="/Team:Tuebingen/SDG" | | <a class="dropdown-item" href="/Team:Tuebingen/SDG" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sustainable Development | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sustainable Development Goals</a> |
| − | Goals</a>
| + | |
| | <a class="dropdown-item" href="/Team:Tuebingen/Experimenta" | | <a class="dropdown-item" href="/Team:Tuebingen/Experimenta" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experimenta Science | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experimenta |
| − | Center</a> | + | Science Center</a> |
| | + | <a class="dropdown-item" href="/Team:Tuebingen/Survey" |
| | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Survey</a> |
| | </div> | | </div> |
| | </li> | | </li> |
| Line 10,377: |
Line 10,382: |
| | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Integrated Human Practise</a> | | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Integrated Human Practise</a> |
| | <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement" | | <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public Engagement</a> |
| − | Engagement</a>
| + | |
| | <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship" | | <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Supporting | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Supporting Entrepreneurship</a> |
| − | Entrepreneurship</a>
| + | |
| − | <a class="dropdown-item" href="/Team:Tuebingen/Measurement"
| + | |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Measurement</a>
| + | |
| | <a class="dropdown-item" href="/Team:Tuebingen/Model" | | <a class="dropdown-item" href="/Team:Tuebingen/Model" |
| | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a> | | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a> |
| Line 10,398: |
Line 10,399: |
| | <li class="nav-item mx-3"> | | <li class="nav-item mx-3"> |
| | <a class="nav-link" href="https://igem.org/2019_Judging_Form?team=Tuebingen" target="_blank" | | <a class="nav-link" href="https://igem.org/2019_Judging_Form?team=Tuebingen" target="_blank" |
| − | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">JUDGING | + | style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">JUDGING FORM ⇗</a> |
| − | FORM ⇗</a>
| + | |
| | </li> | | </li> |
| | | | |
| Line 10,415: |
Line 10,415: |
| | </div> | | </div> |
| | </nav> | | </nav> |
| | + | |
| | </section> | | </section> |
| | <script> | | <script> |
| Line 10,759: |
Line 10,760: |
| | <div class="row"> | | <div class="row"> |
| | <div class="col-12"> | | <div class="col-12"> |
| − | <p>Escherichia coli Nissle 1917 (EcN) is probably | + | <p><i>Escherichia coli</i> Nissle 1917 (EcN) is probably |
| | the most intensively investigated bacterial strain today [1]. Despite the fact that the | | the most intensively investigated bacterial strain today [1]. Despite the fact that the |
| | EcN strain is widely used as a probiotic, a lot of questions remain. Hence, we decided to | | EcN strain is widely used as a probiotic, a lot of questions remain. Hence, we decided to |
| Line 10,789: |
Line 10,790: |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="A generic square placeholder"></a> | | alt="A generic square placeholder"></a> |
| − | <figcaption style="font-size: small; color: #F4F0DE">Fig. 1: EcN growth in LB medium at pH 7. All cultures were inoculated | + | <figcaption style="font-size: small; color: #F4F0DE">Figure 1: EcN growth in LB medium at pH 7. All cultures were inoculated |
| | with an overnight culture and grown for 120 minutes at 37°C. Next, the temperature was | | with an overnight culture and grown for 120 minutes at 37°C. Next, the temperature was |
| | changed to 0°C, 4°C, 8°C and 25°C, while one control was kept at 37°C. Shown are mean | | changed to 0°C, 4°C, 8°C and 25°C, while one control was kept at 37°C. Shown are mean |
| Line 10,809: |
Line 10,810: |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="A generic square placeholder"></a> | | alt="A generic square placeholder"></a> |
| − | <figcaption style="font-size: small; color: #F4F0DE">Fig.2: EcN growth curve in LB at 37°C under different pH levels. Until | + | <figcaption style="font-size: small; color: #F4F0DE">Figure 2: EcN growth curve in LB at 37°C under different pH levels. Until |
| | 120 min all cultures inoculated from one overnight culture grew at pH 7. Then, media was | | 120 min all cultures inoculated from one overnight culture grew at pH 7. Then, media was |
| | changed to the respective pH and cultures were grown for 3 hours. pH 5 and pH 6 grew as usual, | | changed to the respective pH and cultures were grown for 3 hours. pH 5 and pH 6 grew as usual, |
| Line 10,826: |
Line 10,827: |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="A generic square placeholder"></a> | | alt="A generic square placeholder"></a> |
| − | <figcaption style="font-size: small; color: #F4F0DE">Fig. 3: EcN growth in LB at 37°C with pH changed from pH 7 to pH 4 after | + | <figcaption style="font-size: small; color: #F4F0DE">Figure 3: EcN growth in LB at 37°C with pH changed from pH 7 to pH 4 after |
| | two hours of growth. After 150 minutes within pH 4, EcN started to grow comparable to pH 7 | | two hours of growth. After 150 minutes within pH 4, EcN started to grow comparable to pH 7 |
| | cultures. Shown are the three cultures inoculated from the same overnight culture of EcN. </figcaption> | | cultures. Shown are the three cultures inoculated from the same overnight culture of EcN. </figcaption> |
| Line 10,838: |
Line 10,839: |
| | href="https://2019.igem.org/wiki/images/b/bf/T--Tuebingen--H2O2-triplicates-white.png" | | href="https://2019.igem.org/wiki/images/b/bf/T--Tuebingen--H2O2-triplicates-white.png" |
| | data-effect="mfp-zoom-out" | | data-effect="mfp-zoom-out" |
| − | title="Some title"> | + | title="Fig. 4: EcN growth in different concentrations of Hydrogen Peroxide"> |
| | <img src="https://2019.igem.org/wiki/images/b/bf/T--Tuebingen--H2O2-triplicates-white.png" | | <img src="https://2019.igem.org/wiki/images/b/bf/T--Tuebingen--H2O2-triplicates-white.png" |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="A generic square placeholder"></a> | | alt="A generic square placeholder"></a> |
| − | <figcaption style="font-size: small; color: #F4F0DE">Fig. 4: EcN growth in different concentrations of Hydrogen Peroxide, | + | <figcaption style="font-size: small; color: #F4F0DE">Figure 4: EcN growth in different concentrations of Hydrogen Peroxide, |
| | infused after two hours of growth at 37°C, pH 7 in LB medium. 100 µM Hydrogen Peroxide with | | infused after two hours of growth at 37°C, pH 7 in LB medium. 100 µM Hydrogen Peroxide with |
| | slightly inhibited growth. Shown are the means of triplicates for each concentration.</figcaption> | | slightly inhibited growth. Shown are the means of triplicates for each concentration.</figcaption> |
| Line 10,855: |
Line 10,856: |
| | href="https://2019.igem.org/wiki/images/9/90/T--Tuebingen--Dryfreeze-white.png" | | href="https://2019.igem.org/wiki/images/9/90/T--Tuebingen--Dryfreeze-white.png" |
| | data-effect="mfp-zoom-out" | | data-effect="mfp-zoom-out" |
| − | title="Some title"> | + | title="Fig. 5: EcN growth of cultures previously subjected to a dryfreeze protocol"> |
| | <img src="https://2019.igem.org/wiki/images/9/90/T--Tuebingen--Dryfreeze-white.png" | | <img src="https://2019.igem.org/wiki/images/9/90/T--Tuebingen--Dryfreeze-white.png" |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="A generic square placeholder"></a> | | alt="A generic square placeholder"></a> |
| − | <figcaption style="font-size: small; color: #F4F0DE">Fig. 5: EcN growth of cultures previously subjected to a dryfreeze protocol. | + | <figcaption style="font-size: small; color: #F4F0DE">Figure 5: EcN growth of cultures previously subjected to a dryfreeze protocol. |
| | Shown are the mean values of triplicates of cultures grown at 37°C, pH 7 in LB grown for recovery. </figcaption> | | Shown are the mean values of triplicates of cultures grown at 37°C, pH 7 in LB grown for recovery. </figcaption> |
| | </figure> | | </figure> |
| Line 10,880: |
Line 10,881: |
| | href="https://2019.igem.org/wiki/images/b/b2/T--Tuebingen--anaerobic-all-4x-white.png" | | href="https://2019.igem.org/wiki/images/b/b2/T--Tuebingen--anaerobic-all-4x-white.png" |
| | data-effect="mfp-zoom-out" | | data-effect="mfp-zoom-out" |
| − | title="Some title"> | + | title="Fig. 6: EcN growth under four anaerobic conditions compared to EcN |
| | + | aerobic growth"> |
| | <img src="https://2019.igem.org/wiki/images/b/b2/T--Tuebingen--anaerobic-all-4x-white.png" | | <img src="https://2019.igem.org/wiki/images/b/b2/T--Tuebingen--anaerobic-all-4x-white.png" |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="A generic square placeholder"></a> | | alt="A generic square placeholder"></a> |
| − | <figcaption style="font-size: small; color: #F4F0DE">Fig. 6: EcN growth under four anaerobic conditions compared to EcN | + | <figcaption style="font-size: small; color: #F4F0DE">Figure 6: EcN growth under four anaerobic conditions compared to EcN |
| | aerobic growth. Shown are the mean values of four samples inoculated with the | | aerobic growth. Shown are the mean values of four samples inoculated with the |
| | same overnight culture. Experiments were conducted at 37°C and pH 7. LB aerobic growth as | | same overnight culture. Experiments were conducted at 37°C and pH 7. LB aerobic growth as |
| Line 10,908: |
Line 10,910: |
| | href="https://2019.igem.org/wiki/images/7/74/T--Tuebingen--bacterial-SN-white.png" | | href="https://2019.igem.org/wiki/images/7/74/T--Tuebingen--bacterial-SN-white.png" |
| | data-effect="mfp-zoom-out" | | data-effect="mfp-zoom-out" |
| − | title="Some title"> | + | title="Fig. 7: EcN growth in mGAM medium under anaerobic conditions at 37°C,pH 7"> |
| | <img src="https://2019.igem.org/wiki/images/7/74/T--Tuebingen--bacterial-SN-white.png" | | <img src="https://2019.igem.org/wiki/images/7/74/T--Tuebingen--bacterial-SN-white.png" |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="A generic square placeholder"></a> | | alt="A generic square placeholder"></a> |
| − | <figcaption style="font-size: small; color: #F4F0DE">Fig. 7: EcN growth in mGAM medium under anaerobic conditions at 37°C, | + | <figcaption style="font-size: small; color: #F4F0DE">Figure 7: EcN growth in mGAM medium under anaerobic conditions at 37°C, |
| | pH 7 supplemented with either 50% supernatant of different species or 50% of water as a control | | pH 7 supplemented with either 50% supernatant of different species or 50% of water as a control |
| | for depleted nutrients. All cultures were inoculated with the same overnight culture of EcN. | | for depleted nutrients. All cultures were inoculated with the same overnight culture of EcN. |
| Line 10,922: |
Line 10,924: |
| | </div> | | </div> |
| | | | |
| − | <h2 style="font-family:'Righteous';">RNASeq</h2> | + | <h2 style="font-family:'Righteous';">RNA-Seq</h2> |
| | <div class="row"> | | <div class="row"> |
| | <div class="col-12"> | | <div class="col-12"> |
| Line 10,938: |
Line 10,940: |
| | </p> | | </p> |
| | <p> | | <p> |
| − | The generated RNA-Seq read data is then analyzed according to a sample RNA-Seq work-flow (Fig. 7). | + | The generated RNA-Seq read data is then analyzed according to a sample RNA-Seq work-flow (Fig. 8). |
| | </p> | | </p> |
| | <figure> | | <figure> |
| Line 10,944: |
Line 10,946: |
| | href="https://2019.igem.org/wiki/images/7/7f/T--Tuebingen--RNA-Seq-transparent.png" | | href="https://2019.igem.org/wiki/images/7/7f/T--Tuebingen--RNA-Seq-transparent.png" |
| | data-effect="mfp-zoom-out" | | data-effect="mfp-zoom-out" |
| − | title="Some title"> | + | title="Fig. 7"> |
| | <img src="https://2019.igem.org/wiki/images/7/7f/T--Tuebingen--RNA-Seq-transparent.png" | | <img src="https://2019.igem.org/wiki/images/7/7f/T--Tuebingen--RNA-Seq-transparent.png" |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="A generic square placeholder image with rounded corners in a figure."></a> | | alt="A generic square placeholder image with rounded corners in a figure."></a> |
| − | <figcaption style="color: #F4F0DE; font-size: small">Fig. 7: After several complex library | + | <figcaption style="color: #F4F0DE; font-size: small">Figure 8: After several complex library |
| | preparation steps, the cDNA is sequenced and the generated fragments, called reads, | | preparation steps, the cDNA is sequenced and the generated fragments, called reads, |
| | are saved and subject to subsequent bioinformatic analysis. The reads are mapped against | | are saved and subject to subsequent bioinformatic analysis. The reads are mapped against |
| Line 10,959: |
Line 10,961: |
| | </p> | | </p> |
| | <p> | | <p> |
| − | We set ourselves the goal of understanding the transcriptomic changes that EcN undergoes under | + | We set ourselves the goal of understanding the transcriptomic changes that<i>E. coli</i> Nissle 1917 undergoes under |
| | various stress conditions to gain a deeper insight into its responses. Understanding these stress | | various stress conditions to gain a deeper insight into its responses. Understanding these stress |
| − | responses of E. coli Nissle 1917 could lead to the development of more robust strains, which not | + | responses of <i>E. coli</i> Nissle 1917 could lead to the development of more robust strains, which not |
| | only our project would benefit from, but also scientists working on probiotic drugs in general. | | only our project would benefit from, but also scientists working on probiotic drugs in general. |
| | </p> | | </p> |
| | <p> | | <p> |
| | We divided our experimental design into two parts. One part was to investigate the | | We divided our experimental design into two parts. One part was to investigate the |
| − | effect of environmental stress on E. coli Nissle 1917 under aerobic conditions, the | + | effect of environmental stress on <i>E. coli</i> Nissle 1917 under aerobic conditions, the |
| | other part was to examine the responses under anaerobic conditions. Hence, our experimental | | other part was to examine the responses under anaerobic conditions. Hence, our experimental |
| | design looks as follows: | | design looks as follows: |
| | </p> | | </p> |
| − | <table class="veggie"> | + | <figure> |
| − | <caption>Table 1: Conditions of RNA-Seq samples. Overnight cultures of EcN were
| + | <a style="font-size: small" |
| − | inoculated under the respective conditions and pelleted when OD600=0.8 to 1.0 was
| + | href="https://2019.igem.org/wiki/images/4/4f/T--Tuebingen--nissleaerobanaerob.png" |
| − | reached. Pellets were resuspended in RNAlater and prepared for RNA sequencing.</caption>
| + | data-effect="mfp-zoom-out" title=""> |
| − | <tbody>
| + | <img src="https://2019.igem.org/wiki/images/4/4f/T--Tuebingen--nissleaerobanaerob.png" |
| − | <th>Aerobic</th>
| + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| − | <th>Anaerobic</th>
| + | </figure> |
| − | <tr>
| + | |
| − | <td>LB, pH 7, 37°C</td>
| + | |
| − | <td>LB, pH7, 37°C</td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>LB, pH7, 25°C</td> | + | |
| − | <td>mGAM, pH7, 37°C</td> | + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>LB, pH7, 8°C</td>
| + | |
| − | <td>mGAM + Metformin, pH7, 37°C</td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>LB, pH4, 37°C</td>
| + | |
| − | <td>mGAM + Cholic Acid, pH7, 37°C</td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>LB, 100µM H2O2, 37°C</td>
| + | |
| − | <td>mGAM + Bacteroides SN, pH7, 37°C</td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>LB, 37°C post dry-freeze, pH7</td>
| + | |
| − | <td>Control, aerobic, LB, pH7, 37°C</td>
| + | |
| − | </tr>
| + | |
| − | </tbody> | + | |
| − | </table>
| + | |
| | <p> | | <p> |
| | The respective temperature, pH values, and doses were determined by growth curves (Figures 1-6). | | The respective temperature, pH values, and doses were determined by growth curves (Figures 1-6). |
| | To get the most out of RNA-Seq applied to stress factors, it is important to find the cutoff values, | | To get the most out of RNA-Seq applied to stress factors, it is important to find the cutoff values, |
| − | where E. coli Nissle 1917 is put under stress the most, but still survives. | + | where <i>E. coli</i> Nissle 1917 is put under stress the most, but still survives. |
| | </p> | | </p> |
| | <p> | | <p> |
| Line 11,061: |
Line 11,037: |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="Placeholder"></a> | | alt="Placeholder"></a> |
| − | <figcaption style="font-size: small; color: #F4F0DE;">Fig. 8: Sequencing quality histogram. The Phred score, a simple | + | <figcaption style="font-size: small; color: #F4F0DE;">Figure 9: Sequencing quality histogram. The Phred score, a simple |
| | quality metric, is plotted against the position in the read. The quality of the bases at | | quality metric, is plotted against the position in the read. The quality of the bases at |
| | every position is well above 30 and in the safe, green area. The usual phasing problem, | | every position is well above 30 and in the safe, green area. The usual phasing problem, |
| Line 11,070: |
Line 11,046: |
| | <p> | | <p> |
| | The quality of the reads at every position has a Phred score of at least 32, demonstrating that | | The quality of the reads at every position has a Phred score of at least 32, demonstrating that |
| − | the sequencing quality is very high (Figure 8). Moreover, the usually observed decline in quality | + | the sequencing quality is very high (Figure 9). Moreover, the usually observed decline in quality |
| | at the end of the reads due to phasing is exceptionally small. | | at the end of the reads due to phasing is exceptionally small. |
| | </p> | | </p> |
| Line 11,086: |
Line 11,062: |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="Placeholder"></a> | | alt="Placeholder"></a> |
| − | <figcaption style="font-size: small; color: #F4F0DE;">Fig. 9: DupRadar generated general linear models - a summary of the gene | + | <figcaption style="font-size: small; color: #F4F0DE;">Figure 9: DupRadar generated general linear models - a summary of the gene |
| | duplication distributions. Each of the differently colored lines represent one sample. | | duplication distributions. Each of the differently colored lines represent one sample. |
| | The expression in reads per kilobase pair is shown on the x-axis against duplicate reads in | | The expression in reads per kilobase pair is shown on the x-axis against duplicate reads in |
| Line 11,125: |
Line 11,101: |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="Placeholder"></a> | | alt="Placeholder"></a> |
| − | <figcaption style="font-size: small; color: #F4F0DE;">Fig. 10: MDS plot showing the euclidean distances between all samples. The creation | + | <figcaption style="font-size: small; color: #F4F0DE;">Figure 10: MDS plot showing the euclidean distances between all samples. The creation |
| | of the distances is based on the log-counts-per-million and the log2 fold changes. The respective four | | of the distances is based on the log-counts-per-million and the log2 fold changes. The respective four |
| | replicates of all conditions and controls cluster very nicely, verifying that our libraries were well | | replicates of all conditions and controls cluster very nicely, verifying that our libraries were well |
| Line 11,143: |
Line 11,119: |
| | class="figure-img img-fluid rounded" | | class="figure-img img-fluid rounded" |
| | alt="Placeholder"></a> | | alt="Placeholder"></a> |
| − | <figcaption style="font-size: small; color: #F4F0DE;">Fig. 11: FeatureCounts plot plotting the number of reads against the percentages | + | <figcaption style="font-size: small; color: #F4F0DE;">Figure 11: FeatureCounts plot plotting the number of reads against the percentages |
| | of different biological entities. Protein coding reads are largely dominating, with rRNA mapping reads | | of different biological entities. Protein coding reads are largely dominating, with rRNA mapping reads |
| | occurring to a far smaller degree. Besides sRNA, no other RNA type is observed in an unusual quantity.</figcaption> | | occurring to a far smaller degree. Besides sRNA, no other RNA type is observed in an unusual quantity.</figcaption> |
| Line 11,162: |
Line 11,138: |
| | </p> | | </p> |
| | <h3 style="font-family: Righteous; color: #2ecc71;">Differential Expression Analysis</h3> | | <h3 style="font-family: Righteous; color: #2ecc71;">Differential Expression Analysis</h3> |
| − | <h3 style="font-family: Righteous; color: #2ecc71;">Pathway Analysis</h3>
| |
| − | <h3 style="font-family: Righteous; color: #2ecc71;">Metabolic Model</h3>
| |
| | <p> | | <p> |
| − | Our E. coli Nissle 1917 characterization includes our metabolic modeling. Please visit our | + | To evaluate the results of our RNA-Seq experiments, we performed a differential expression |
| − | <a href="https://2019.igem.org/Team:Tuebingen/model" onclick='window.open("https://2019.igem.org/Team:Tuebingen/model","_self");'>model</a> subpage for more details. | + | analysis using DESeq2. This allows identifying the genes which are differentially expressed |
| | + | between the anaerobe control and the respective treatment conditions. Looking at the list of |
| | + | differentially expressed genes allows first interpretations of the results and give a good |
| | + | starting point for more in-depth analysis. |
| | </p> | | </p> |
| − | </div>
| + | <div class="row align-items-center"> |
| − | </div>
| + | <div class="col-12 col-md-6"> |
| | + | <figure> |
| | + | <a style="font-size: small" |
| | + | href="https://2019.igem.org/wiki/images/d/d8/T--Tuebingen--NissleT1.png" |
| | + | data-effect="mfp-zoom-out" title="Table 1: Most differentially expressed |
| | + | genes for the aerobe sample ordered descendingly by p-value"> |
| | + | <img src="https://2019.igem.org/wiki/images/d/d8/T--Tuebingen--NissleT1.png" |
| | + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| | + | <figcaption style="color: #F4F0DE; font-size: small">Table 1: Most differentially expressed |
| | + | genes for the aerobe sample ordered descendingly by p-value.</figcaption> |
| | + | </figure> |
| | | | |
| − | <h2 style="font-family:'Righteous'; color:#2ecc71;">Metabolic Model</h2>
| + | </div> |
| | + | <div class="col-12 col-md-6 "> |
| | + | <figure> |
| | + | <a style="font-size: small" |
| | + | href="https://2019.igem.org/wiki/images/4/4c/T--Tuebingen--NissleT2.png" |
| | + | data-effect="mfp-zoom-out" title="Table 2: Most differentially expressed genes for the |
| | + | mGAM sample ordered descendingly by p-value."> |
| | + | <img src="https://2019.igem.org/wiki/images/4/4c/T--Tuebingen--NissleT2.png" |
| | + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| | + | <figcaption style="color: #F4F0DE; font-size: small">Table 2: Most differentially expressed |
| | + | genes for the mGAM sample ordered descendingly by p-value.</figcaption> |
| | + | </figure> |
| | + | </div> |
| | + | </div> |
| | | | |
| | + | <div class="row align-items-center"> |
| | + | <div class="col-12 col-md-6"> |
| | + | <figure> |
| | + | <a style="font-size: small" |
| | + | href="https://2019.igem.org/wiki/images/7/79/T--Tuebingen--NissleT3.png" |
| | + | data-effect="mfp-zoom-out" title="Table 3: Most differentially expressed |
| | + | genes for the aerobe sample ordered descendingly by p-value"> |
| | + | <img src="https://2019.igem.org/wiki/images/7/79/T--Tuebingen--NissleT3.png" |
| | + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| | + | <figcaption style="color: #F4F0DE; font-size: small">Table 3: Most differentially expressed |
| | + | genes for the bile acid sample ordered descendingly by p-value.</figcaption> |
| | + | </figure> |
| | | | |
| − | <div class="row">
| + | </div> |
| − | <div class="col-12">
| + | <div class="col-12 col-md-6 "> |
| − | <p>Insert here</p> | + | <figure> |
| | + | <a style="font-size: small" |
| | + | href="https://2019.igem.org/wiki/images/6/66/T--Tuebingen--NissleT4.png" |
| | + | data-effect="mfp-zoom-out" title="Table 4: Most differentially expressed genes for the |
| | + | supernatant sample ordered descendingly by p-value."> |
| | + | <img src="https://2019.igem.org/wiki/images/6/66/T--Tuebingen--NissleT4.png" |
| | + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| | + | <figcaption style="color: #F4F0DE; font-size: small">Table 4: Most differentially expressed |
| | + | genes for the supernatant sample ordered descendingly by p-value.</figcaption> |
| | + | </figure> |
| | + | </div> |
| | + | </div> |
| | + | <figure> |
| | + | <a style="font-size: small" |
| | + | href="https://2019.igem.org/wiki/images/3/3b/T--Tuebingen--NissleT5.png" |
| | + | data-effect="mfp-zoom-out" title="Table 5: Most differentially expressed genes for the |
| | + | Metformin sample ordered descendingly by p-value."> |
| | + | <img src="https://2019.igem.org/wiki/images/3/3b/T--Tuebingen--NissleT5.png" |
| | + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| | + | <figcaption style="color: #F4F0DE; font-size: small">Table 5: Most differentially expressed |
| | + | genes for the Metformin sample ordered descendingly by p-value.</figcaption> |
| | + | </figure> |
| | + | |
| | + | <p> |
| | + | The conditions bile acid, metformin, bacterial supernatant, and mGAM all share common genes among |
| | + | the Top 10 differentially expressed genes. The anaerobic sn-glycerol-3-phosphate dehydrogenase |
| | + | is the most differentially expressed gene in all those conditions, with a log2Fold change greater |
| | + | than 8. Other prominent gens are the succinate-semialdehyde dehydrogenase (NADP+) which is highly |
| | + | upregulated in the mGAM, metformin and bile acid sample and the Zn-dependent periplasmic chaperone, |
| | + | which is downregulated in all samples except the supernatant treatment. |
| | + | </p> |
| | + | |
| | + | <p> |
| | + | In general, the most differentially expressed gene set of the aerobe treatment against the |
| | + | anaerobe control is more dissimilar to the other conditions. A more in-depth functional analysis |
| | + | can be performed using GO term enrichment or pathway analysis. |
| | + | </p> |
| | + | <h3 style="font-family: Righteous; color: #2ecc71;">Enrichment</h3> |
| | + | <p> |
| | + | To identify groups of genes that are overrepresented under treatment conditions, gene set |
| | + | enrichments for common gene ontology (GO) terms and pathways were performed. GO terms are |
| | + | standardized functions, processes or components defined by the GO initiative across all species, |
| | + | which facilitate functional interpretation of experimental data. The enrichment allows summarizing |
| | + | the large list of differentially expressed genes into a smaller list of affected biological |
| | + | processes that changed most on the treatment. We highly recommend to download our |
| | + | <a href="https://2019.igem.org/Team:Tuebingen/Downloads" onclick='window.open("https://2019.igem.org/Team:Tuebingen/Downloads","_self");'>Parts / Downloads</a> site to download far more plots of the enrichment analysis, than we can show on this page. |
| | + | </p> |
| | + | <p> |
| | + | The GO enrichment funneled hundreds of differentially expressed genes into a few easily interpretable categories for the anaerobic and aerobic samples cultivated in LB medium, and bile acid and Metformin treated cultivated in mGAM medium under anaerobic conditions. Each sample was compared against an anaerobic cultivated control in the mGAM medium. The Metformin and bile acid-treated samples, both cultivated in mGAM medium, had the least number of differentially expressed genes. The aerobic and anaerobic sample grown in LB medium and the sample treated with bacterial supernatant had a much larger number of differentially expressed genes. |
| | + | </p> |
| | + | <div class="row align-items-center"> |
| | + | <div class="col-12 col-md-5"> |
| | + | <figure> |
| | + | <a style="font-size: small" |
| | + | href="https://2019.igem.org/wiki/images/8/8e/T--Tuebingen--anaerobe_dotplot.png" |
| | + | data-effect="mfp-zoom-out" title="Fig. 12: Dot plot of enriched |
| | + | GO terms for aerobe (LB) vs anaerobe control (mGAM) (p-value cutoff: 0.01)"> |
| | + | <img src="https://2019.igem.org/wiki/images/8/8e/T--Tuebingen--anaerobe_dotplot.png" |
| | + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| | + | <figcaption style="color: #F4F0DE; font-size: small">Figure 12: Dot plot of enriched |
| | + | GO terms for aerobe (LB) vs anaerobe control (mGAM) (p-value cutoff: 0.01)</figcaption> |
| | + | </figure> |
| | + | |
| | + | </div> |
| | + | <div class="col-12 col-md-7"> |
| | + | <p> |
| | + | Under aerobic conditions with the typical LB medium, the most significant GO terms are related to cellular respiration and oxidation-reduction processes (Fig. 12). Those effects can be explained by the drastic condition changes compared to the anaerobic control grown under the mGAM medium. Those drastic changes in gene expression of <i>E. coli</i> Nissle 1917 highlight the difference between typical lab conditions, aerobic and LB medium, and the conditions in the human gut, which we tried to model with our control sample. |
| | + | </p> |
| | + | </div> |
| | + | </div> |
| | + | |
| | + | <div class="row align-items-center"> |
| | + | <div class="col-12 col-md-7"> |
| | + | <p> |
| | + | Bile acid treatment results in the enrichment of GO terms related to RNA processing (Fig. 13). In general, the effect of bile acid on the gut microbiome can be explained by the amphipathic nature of the molecule, which is largely involved in shaping the gut composition. Moreover, also processes related to hydrolase activity are directly affected by bile acid treatment of <i>E. coli</i> Nissle 1917. |
| | + | </p> |
| | + | </div> |
| | + | <div class="col-12 col-md-5"> |
| | + | <figure> |
| | + | <a style="font-size: small" |
| | + | href="https://2019.igem.org/wiki/images/f/ff/T--Tuebingen--bileacid_dotplot.png" |
| | + | data-effect="mfp-zoom-out" title="Fig. 13: Dot plot of enriched GO terms for bile |
| | + | acid (mGAM) vs anaerobe control (mGAM) (p-value cutoff: 0.01)"> |
| | + | <img src="https://2019.igem.org/wiki/images/f/ff/T--Tuebingen--bileacid_dotplot.png" |
| | + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| | + | <figcaption style="color: #F4F0DE; font-size: small">Figure 13: Dot plot of enriched |
| | + | GO terms for bile acid (mGAM) vs anaerobe control (mGAM) (p-value cutoff: 0.01)</figcaption> |
| | + | </figure> |
| | + | </div> |
| | + | </div> |
| | + | |
| | + | <div class="row align-items-center"> |
| | + | <div class="col-12 col-md-5"> |
| | + | <figure> |
| | + | <a style="font-size: small" |
| | + | href="https://2019.igem.org/wiki/images/4/4e/T--Tuebingen--metformin_dotplot.png" |
| | + | data-effect="mfp-zoom-out" title="Fig. 14: Dot plot of enriched |
| | + | GO terms for metformin (mGAM) vs anaerobe control (mGAM) (p-value cutoff: 0.01)"> |
| | + | <img src="https://2019.igem.org/wiki/images/4/4e/T--Tuebingen--metformin_dotplot.png" |
| | + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| | + | <figcaption style="color: #F4F0DE; font-size: small">Figure 14: Dot plot of enriched |
| | + | GO terms for metformin (mGAM) vs anaerobe control (mGAM) (p-value cutoff: 0.01)</figcaption> |
| | + | </figure> |
| | + | |
| | + | </div> |
| | + | <div class="col-12 col-md-7"> |
| | + | <p> |
| | + | Metformin treated samples show an upregulation of flagellum related genes (Fig. 14). Increased bacterial motility is a well-known response to various stress factors, meant to move away from the stress-inducing source. |
| | + | </p> |
| | + | </div> |
| | + | </div> |
| | + | |
| | + | <div class="row align-items-center"> |
| | + | <div class="col-12 col-md-7"> |
| | + | <p> |
| | + | Cultivation of <i>E. coli</i> Nissle 1917 in LB medium under anaerobic conditions affect processes related to cellular respiration and metabolite uptake (Fig. 15). This can be explained by the differences in the culture medium (LB medium vs. mGAM medium), which both have different compositions. Therefore using the typical LB medium for the cultivation of <i>E. coli</i> Nissle 1917, the response and general behavior of the bacterium might differ from the reaction under the conditions in the human gut, which were modeled using the mGAM medium. |
| | + | </p> |
| | + | </div> |
| | + | <div class="col-12 col-md-5"> |
| | + | <figure> |
| | + | <a style="font-size: small" |
| | + | href="https://2019.igem.org/wiki/images/5/56/T--Tuebingen--anaerobe_dotplot_title.png" |
| | + | data-effect="mfp-zoom-out" title="Fig. 15: Dot plot of enriched GO terms for anaerobe (LB) vs anaerobe control (mGAM) (p-value cutoff: 0.01)"> |
| | + | <img src="https://2019.igem.org/wiki/images/5/56/T--Tuebingen--anaerobe_dotplot_title.png" |
| | + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| | + | <figcaption style="color: #F4F0DE; font-size: small">Figure 15: Dot plot of enriched |
| | + | GO terms for anaerobe (LB) vs anaerobe control (mGAM) (p-value cutoff: 0.01)</figcaption> |
| | + | </figure> |
| | + | </div> |
| | + | </div> |
| | + | |
| | + | <div class="row align-items-center"> |
| | + | <div class="col-12 col-md-5"> |
| | + | <figure> |
| | + | <a style="font-size: small" |
| | + | href="https://2019.igem.org/wiki/images/2/20/T--Tuebingen--supernatant_dotplot_title.png" |
| | + | data-effect="mfp-zoom-out" title="Fig. 16: Dot plot of enriched GO terms for bacterial supernatant (mGAM) vs anaerobe control (mGAM) (p-value cutoff: 0.01)"> |
| | + | <img src="https://2019.igem.org/wiki/images/2/20/T--Tuebingen--supernatant_dotplot_title.png" |
| | + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| | + | <figcaption style="color: #F4F0DE; font-size: small">Figure 16: Dot plot of enriched |
| | + | GO terms for bacterial supernatant (mGAM) vs anaerobe control (mGAM) (p-value cutoff: 0.01)</figcaption> |
| | + | </figure> |
| | + | </div> |
| | + | <div class="col-12 col-md-7"> |
| | + | <p> |
| | + | Using bacterial supernatant for the cultivation of <i>E. coli</i> Nissle 1917, to simulate the effects of cocultivation of different bacteria, results in the enrichment of gene groups related to ribosome and ribosome binding, which are significantly downregulated (Fig. 16). Therefore, all protein translations processes of the bacterium are affected. |
| | + | </p> |
| | + | </div> |
| | + | </div> |
| | + | |
| | + | <div class="row align-items-center"> |
| | + | <div class="col-12 col-md-7"> |
| | + | <p> |
| | + | Since our probiotic system largely relies on the detection of glucose, we investigated |
| | + | the changes in glucose metabolism of <i>E. coli</i> Nissle 1917. Cultivation under aerobic |
| | + | conditions resulted in the upregulation of many glycolysis or ATP-production related genes. |
| | + | The treatment with metformin, bile acid, the bacterial supernatant or anaerobic conditions in LB medium |
| | + | had only little effect on ATP biosynthesis-related genes (Fig. 17). For the four other |
| | + | conditions, besides the aerobic condition, some log2Fold changes can be observed in |
| | + | the cluster heatmap but weren't significant. |
| | + | </p> |
| | + | </div> |
| | + | |
| | + | <div class="col-12 col-md-5"> |
| | + | <figure> |
| | + | <a style="font-size: small" |
| | + | href="https://2019.igem.org/wiki/images/8/82/T--Tuebingen--atpbiosynthesis_cluster.png" |
| | + | data-effect="mfp-zoom-out" title="Fig. 17 Cluster heatmap for ATP-biosynthesis related genes."> |
| | + | <img src="https://2019.igem.org/wiki/images/8/82/T--Tuebingen--atpbiosynthesis_cluster.png" |
| | + | class="figure-img img-fluid rounded" alt="Placeholder"></a> |
| | + | <figcaption style="color: #F4F0DE; font-size: small">Figure 17: Cluster heatmap for |
| | + | ATP-biosynthesis related genes.</figcaption> |
| | + | </figure> |
| | + | |
| | + | </div> |
| | + | </div> |
| | + | <h3 style="font-family: Righteous; color: #2ecc71;">Summary</h3> |
| | + | <p> |
| | + | In general, a clear difference in expression profiles of samples cultivated under aerobic and |
| | + | anaerobic conditions can be observed. This result was expected since the availability of |
| | + | oxygen largely influences the whole metabolism of the bacterium. This is a crucial aspect |
| | + | that has to be considered when working with <i>E. coli</i> Nissle 1917 and in general all bacteria, |
| | + | which are meant to be used as probiotic. In particular, ATP-biosynthesis related genes were |
| | + | upregulated for the samples cultivated under aerobic conditions. |
| | + | </p> |
| | + | <p> |
| | + | Generally, treatment with bile acid, metformin, the bacterial supernatant, and anaerobe cultivation with LB medium resulted in more similar expression profiles than compared to the aerobic samples (LB medium). Our results indicate a potential increase in bacterial motility caused by Metformin, a frequently used drug for Diabetes patients. Moreover, the supernatant of Bacteroides spp., a commonly found bacterium within the human microbiome, resulted in a downregulation of many ribosome-related genes, which indicates an interaction with <i>E. coli</i> Nissle 1917. However, further experiments are required to draw a conclusion. |
| | + | </p> |
| | + | <h2 style="font-family:'Righteous'; color:#2ecc71;">Metabolic Model</h2> |
| | + | <p> |
| | + | Our <i>E. coli</i> Nissle 1917 characterization includes our metabolic modeling. Please visit our |
| | + | <a href="https://2019.igem.org/Team:Tuebingen/model" onclick='window.open("https://2019.igem.org/Team:Tuebingen/model","_self");'>model</a> subpage for more details. |
| | + | </p> |
| | </div> | | </div> |
| | </div> | | </div> |
| − |
| |
| | </div> | | </div> |
| | | | |
| Line 11,214: |
Line 11,417: |
| | <script src="https://2019.igem.org/Team:Tuebingen/popup-imagesJS?action=raw&ctype=text/javascript"></script> | | <script src="https://2019.igem.org/Team:Tuebingen/popup-imagesJS?action=raw&ctype=text/javascript"></script> |
| | | | |
| − | <div class='container-fluid p-3' style="background-color: rgba(35, 35, 35, 0.4);">
| + | <div class='container-fluid p-3' style="background-color: #919191;"> |
| − | <hr>
| + | <hr> |
| − | <div class='row align-items-center'>
| + | <div class='row align-items-center'> |
| − | <div class='col-6 col-md-2 sponsorLogo text-center'>
| + | <div class='col-6 col-md-2 sponsorLogo text-center'> |
| − | <a href="https://www.stura-tuebingen.de/" target="_blank2"><img class="img-fluid"
| + | <a href="https://www.stura-tuebingen.de/" target="_blank2"><img class="img-fluid" |
| − | src="https://2019.igem.org/wiki/images/1/10/T--Tuebingen--stura_logo.png"
| + | src="https://2019.igem.org/wiki/images/1/10/T--Tuebingen--stura_logo.png" |
| − | style="max-height: 80px;"></a>
| + | style="max-height: 80px;"></a> |
| − | </div>
| + | </div> |
| − | <div class='col-6 col-md-2 sponsorLogo text-center'>
| + | |
| − | <a href="https://www.embl.de/" target="_blank2"><img class="img-fluid" | + | <div class='col-6 col-md-2 sponsorLogo text-center'> |
| − | src="https://2019.igem.org/wiki/images/c/c4/T--Tuebingen--embl_logo.png"
| + | <a href="https://www.kohlbacherlab.org" target="_blank2"><img class="img-fluid" |
| − | style="max-height: 80px;"></a>
| + | src="https://2019.igem.org/wiki/images/9/99/T--Tuebingen--kohlbacher_logo.png" |
| − | </div>
| + | style="max-height: 80px;"></a> |
| | + | </div> |
| | + | <div class='col-6 col-md-2 sponsorLogo text-center'> |
| | + | <a href="https://www.dieter-schwarz-stiftung.de/homepage.html" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/8/86/T--Tuebingen--LogoDSS.png" |
| | + | style="max-height: 80px;"></a> |
| | + | </div> |
| | + | |
| | + | <div class='col-6 col-md-2 sponsorLogo text-center'> |
| | + | <a href="https://www.embl.de/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/c/c4/T--Tuebingen--embl_logo.png" |
| | + | style="max-height: 80px;"></a> |
| | + | </div> |
| | + | |
| | + | <div class='col-6 col-md-2 sponsorLogo text-center'> |
| | + | <a href="https://www.experimenta.science/en/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/e/eb/T--Tuebingen--Logo-Experimenta.png" |
| | + | style="max-height: 80px;"></a> |
| | + | </div> |
| | + | |
| | <div class='col-6 col-md-2 sponsorLogo text-center'> | | <div class='col-6 col-md-2 sponsorLogo text-center'> |
| − | <a href="https://www.medizin.uni-tuebingen.de/de/medizinische-fakultaet/forschung/core-facilities/ncct"
| + | <a href="https://www.medizin.uni-tuebingen.de/de/medizinische-fakultaet/forschung/core-facilities/ncct" |
| − | target="_blank2"><img class="img-fluid"
| + | target="_blank2"><img class="img-fluid" |
| − | src="https://2019.igem.org/wiki/images/e/ec/T--Tuebingen--NCCT.png"
| + | src="https://2019.igem.org/wiki/images/e/ec/T--Tuebingen--NCCT.png" |
| − | style="max-height: 80px;"></a>
| + | style="max-height: 80px;"></a> |
| | + | </div> |
| | + | |
| | </div> | | </div> |
| − | <div class='col-6 col-md-2 sponsorLogo text-center'> | + | |
| − | <a href="https://www.kohlbacherlab.org" target="_blank2"><img class="img-fluid"
| + | <hr> |
| − | src="https://2019.igem.org/wiki/images/9/99/T--Tuebingen--kohlbacher_logo.png"
| + | <div class='row align-items-center'> |
| − | style="max-height: 80px;"></a>
| + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.lexogen.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/4/43/T--Tuebingen--lexogen_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.zmbp.uni-tuebingen.de/zmbp.html" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/d/d8/T--Tuebingen--zmbp_logo.png" |
| | + | style="max-height: 80px;"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="http://s466755640.online.de/4bl/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/0/0b/T--Tuebingen--4base_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.agilent.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/e/e7/T--Tuebingen--agilent_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.digitalocean.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/6/67/T--Tuebingen--digitalocean_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://dwk.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/c/ce/T--Tuebingen--dwk_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.eppendorf.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/a/a6/T--Tuebingen--eppendorf_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.implen.de/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/b/bb/T--Tuebingen--Logo-Implen.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.jenabioscience.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/3/31/T--Tuebingen--JBS_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.gbo.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/a/ae/T--Tuebingen--greiner_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="http://www.metabion.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/4/41/T--Tuebingen--Logo-Metabion.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.microsynth.ch/home-ch.html" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/1/18/T--Tuebingen--microsynth_logo.png"></a> |
| | + | </div> |
| | </div> | | </div> |
| − | <div class='col-6 col-md-2 sponsorLogo text-center'> | + | |
| − | <a href="https://www.dieter-schwarz-stiftung.de/homepage.html" target="_blank2"><img class="img-fluid" | + | <div class='row align-items-center'> |
| − | src="https://2019.igem.org/wiki/images/8/86/T--Tuebingen--LogoDSS.png"
| + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| − | style="max-height: 80px;"></a>
| + | <a href="https://www.neb.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/2/29/T--Tuebingen--neb_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.promega.de/en/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/f/f8/T--Tuebingen--promega_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.qiagen.com/us/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/9/92/T--Tuebingen--qiagen_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.carlroth.com/en/en" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/6/61/T--Tuebingen--roth_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.sitoolsbiotech.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/3/31/T--Tuebingen--sibiotools_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.snapgene.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/3/3a/T--Tuebingen--snapgene_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.trilinkbiotech.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/b/b6/T--Tuebingen--trilink_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://twistbioscience.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/4/4c/T--Tuebingen--Logo-Twist.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="http://www.vazymebiotech.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/b/b7/T--Tuebingen--vazyme_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.biolegend.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/c/c3/T--Tuebingen--biolegend_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.zymoresearch.de/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/6/6e/T--Tuebingen--zymo_logo.png"></a> |
| | + | </div> |
| | + | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'> |
| | + | <a href="https://www.eurofins.com/" target="_blank2"><img class="img-fluid" |
| | + | src="https://2019.igem.org/wiki/images/c/cd/T--Tuebingen--eurofins_logo.svg"></a> |
| | + | </div> |
| | + | |
| | </div> | | </div> |
| − |
| |
| − | <div class='col-6 col-md-2 sponsorLogo text-center'>
| |
| − | <a href="https://www.experimenta.science/en/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/e/eb/T--Tuebingen--Logo-Experimenta.png"
| |
| − | style="max-height: 80px;"></a>
| |
| − | </div>
| |
| − |
| |
| | </div> | | </div> |
| − | </div>
| |
| − |
| |
| − | <hr>
| |
| − | <div class='row align-items-center'>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.lexogen.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/4/43/T--Tuebingen--lexogen_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.zmbp.uni-tuebingen.de/zmbp.html" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/d/d8/T--Tuebingen--zmbp_logo.png"
| |
| − | style="max-height: 80px;"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="http://s466755640.online.de/4bl/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/0/0b/T--Tuebingen--4base_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.agilent.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/e/e7/T--Tuebingen--agilent_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.digitalocean.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/6/67/T--Tuebingen--digitalocean_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://dwk.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/c/ce/T--Tuebingen--dwk_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.eppendorf.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/a/a6/T--Tuebingen--eppendorf_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.implen.de/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/b/bb/T--Tuebingen--Logo-Implen.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.jenabioscience.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/3/31/T--Tuebingen--JBS_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.gbo.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/a/ae/T--Tuebingen--greiner_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="http://www.metabion.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/4/41/T--Tuebingen--Logo-Metabion.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.microsynth.ch/home-ch.html" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/1/18/T--Tuebingen--microsynth_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.neb.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/2/29/T--Tuebingen--neb_logo.png"></a>
| |
| − | </div>
| |
| − | </div>
| |
| − |
| |
| − | <div class='row align-items-center'>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.promega.de/en/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/f/f8/T--Tuebingen--promega_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.qiagen.com/us/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/9/92/T--Tuebingen--qiagen_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.carlroth.com/en/en" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/6/61/T--Tuebingen--roth_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.sitoolsbiotech.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/3/31/T--Tuebingen--sibiotools_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.snapgene.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/3/3a/T--Tuebingen--snapgene_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.trilinkbiotech.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/b/b6/T--Tuebingen--trilink_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://twistbioscience.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/4/4c/T--Tuebingen--Logo-Twist.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="http://www.vazymebiotech.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/b/b7/T--Tuebingen--vazyme_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.biolegend.com/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/c/c3/T--Tuebingen--biolegend_logo.png"></a>
| |
| − | </div>
| |
| − | <div class='col-4 col-md-2 col-xl-1 sponsorLogo text-center'>
| |
| − | <a href="https://www.zymoresearch.de/" target="_blank2"><img class="img-fluid"
| |
| − | src="https://2019.igem.org/wiki/images/6/6e/T--Tuebingen--zymo_logo.png"></a>
| |
| − | </div>
| |
| − |
| |
| − | </div>
| |
| − | </div>
| |
| | | | |
| | <script src="https://2019.igem.org/Team:Tuebingen/magni-popup-minJS?action=raw&ctype=text/javascript"></script> | | <script src="https://2019.igem.org/Team:Tuebingen/magni-popup-minJS?action=raw&ctype=text/javascript"></script> |